Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-02-11 Sale | 2021-02-16 7:35 pm | Monopar Therapeutics | MNPR | Tactic Pharma LLC Mazar Andrew Paul Robinson Chandler O'Halloran Thomas V. Brown Michael J 10% Owner | 125,000 | $14.64 | $1,830,620 | 4,277,940 (Indirect Direct) | View |
| 2019-12-18 Purchase | 2019-12-20 6:33 pm | Monopar Therapeutics | MNPR | Tactic Pharma LLC Mazar Andrew Paul Robinson Chandler O'Halloran Thomas V. Brown Michael J 10% Owner | 125,000 | $8 | $1,000,000 | 4,402,940 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-31 Exercise | 2024-04-02 8:33 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 24,474 | $0 | 4,641,882 (Direct) | View |
| 2024-03-31 Tax Withholding | 2024-04-02 8:33 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 7,172 | $0.681 | 4,641,882 (Direct) | View |
| 2023-12-31 Exercise | 2024-01-03 7:36 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 31,198 | $0 | 9,156,003 (Direct) | View |
| 2023-12-31 Tax Withholding | 2024-01-03 7:36 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 10,796 | $0.3402 | 9,156,003 (Direct) | View |
| 2023-09-30 Exercise | 2023-10-03 7:37 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 24,474 | $0 | 4,659,850 (Direct) | View |
| 2023-09-30 Tax Withholding | 2023-10-03 7:37 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 7,172 | $0.6199 | 4,659,850 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-03 6:45 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 35,039 | $0 | 4,667,022 (Direct) | View |
| 2023-06-30 Tax Withholding | 2023-07-03 6:45 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 10,269 | $0.855 | 4,667,022 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-04 5:17 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 13,911 | $0 | 4,677,291 (Direct) | View |
| 2023-03-31 Tax Withholding | 2023-04-04 5:17 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 4,286 | $1.39 | 4,677,291 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 6:49 pm | N/A 2033-02-01 | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 390,851 | $0 | 548,746 (Direct) | View |
| 2022-12-31 Exercise | 2023-01-03 3:59 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 20,635 | $0 | 8,790,505 (Direct) | View |
| 2022-12-31 Tax Withholding | 2023-01-03 3:59 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 7,141 | $2.37 | 8,790,505 (Direct) | View |
| 2022-09-30 Exercise | 2022-10-03 7:55 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 13,911 | $0 | 4,519,706 (Direct) | View |
| 2022-09-30 Tax Withholding | 2022-10-03 7:55 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 4,077 | $1.52 | 4,519,706 (Direct) | View |
| 2022-06-30 Exercise | 2022-07-01 4:07 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 23,882 | $0 | 4,523,783 (Direct) | View |
| 2022-06-30 Tax Withholding | 2022-07-01 4:07 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 6,999 | $2.299 | 4,523,783 (Direct) | View |
| 2022-03-31 Exercise | 2022-04-01 5:28 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 3,941 | $0 | 4,530,782 (Direct) | View |
| 2022-03-31 Tax Withholding | 2022-04-01 5:28 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 1,155 | $2.55 | 4,530,782 (Direct) | View |
| 2022-02-02 Option Award | 2022-02-04 7:37 pm | N/A 2032-02-01 | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 370,540 | $0 | 431,282 (Direct) | View |
| 2022-01-01 Exercise | 2022-01-04 2:17 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 6,724 | $0 | 4,325,120 (Direct) | View |
| 2022-01-01 Tax Withholding | 2022-01-04 2:17 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 2,327 | $3.21 | 4,325,120 (Direct) | View |
| 2021-12-31 Exercise | 2022-01-04 2:07 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 3,941 | $0 | 4,354,571 (Direct) | View |
| 2021-12-31 Tax Withholding | 2022-01-04 2:07 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 1,364 | $3.21 | 4,354,571 (Direct) | View |
| 2021-09-30 Exercise | 2021-10-01 7:24 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 3,941 | $0 | 4,355,935 (Direct) | View |
| 2021-09-30 Tax Withholding | 2021-10-01 7:24 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 1,155 | $4.87 | 4,355,935 (Direct) | View |
| 2021-06-30 Exercise | 2021-07-02 5:10 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 7,883 | $0 | 4,357,090 (Direct) | View |
| 2021-06-30 Tax Withholding | 2021-07-02 5:10 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 2,310 | $5.89 | 4,357,090 (Direct) | View |
| 2021-01-26 Option Award | 2021-01-28 6:51 pm | N/A 2031-01-25 | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 133,060 | $0 | 153,231 (Direct) | View |
| 2021-01-01 Exercise | 2021-01-05 5:40 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 6,724 | $0 | 4,441,511 (Direct) | View |
| 2021-01-01 Tax Withholding | 2021-01-05 5:40 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 2,327 | $6.12 | 4,441,511 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-20 8:58 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 138,648 | $0 | 138,648 (Direct) | View |